Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The immune response to SARS-CoV-2 in people with HIV
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV infection
More than 75 million people worldwide have been infected with human immunodeficiency
virus (HIV), and there are now approximately 37 million individuals living with the infection …
virus (HIV), and there are now approximately 37 million individuals living with the infection …
Immune activation and HIV persistence: implications for curative approaches to HIV infection
NR Klatt, N Chomont, DC Douek… - Immunological …, 2013 - Wiley Online Library
Despite complete or near‐complete suppression of human immunodeficiency virus (HIV)
replication with combination antiretroviral therapy, both HIV and chronic …
replication with combination antiretroviral therapy, both HIV and chronic …
Effect of early versus deferred antiretroviral therapy for HIV on survival
Background The optimal time for the initiation of antiretroviral therapy for asymptomatic
patients with human immunodeficiency virus (HIV) infection is uncertain. Methods We …
patients with human immunodeficiency virus (HIV) infection is uncertain. Methods We …
Pathogenic mechanisms of HIV disease
Human immunodeficiency virus (HIV) infection is generally characterized by inefficient viral
transmission; an acute phase of intense viral replication and dissemination to lymphoid …
transmission; an acute phase of intense viral replication and dissemination to lymphoid …
Antiretroviral therapy and management of HIV infection
PA Volberding, SG Deeks - The Lancet, 2010 - thelancet.com
Antiretroviral therapy of HIV infection has changed a uniformly fatal into a potentially chronic
disease. There are now 17 drugs in common use for HIV treatment. Patients who can access …
disease. There are now 17 drugs in common use for HIV treatment. Patients who can access …
Residual immune dysregulation syndrome in treated HIV infection
MM Lederman, NT Funderburg, RP Sekaly… - Advances in …, 2013 - Elsevier
Antiretroviral therapy has revolutionized the course of HIV infection, improving immune
function and decreasing dramatically the mortality and morbidity due to the opportunistic …
function and decreasing dramatically the mortality and morbidity due to the opportunistic …
Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
Background. Elevated immune activation persists during treated human immunodeficiency
virus (HIV) infection and is associated with blunted CD4 recovery and premature mortality …
virus (HIV) infection and is associated with blunted CD4 recovery and premature mortality …
Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells
Background. Studies aimed at defining the association between host immune responses
and human immunodeficiency virus (HIV) persistence during therapy are necessary to …
and human immunodeficiency virus (HIV) persistence during therapy are necessary to …
Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts
L Hocqueloux, V Avettand-Fenoël… - Journal of …, 2013 - academic.oup.com
Objectives To characterize viro-immunological outcomes following long-term combined
antiretroviral therapy (cART) initiated during primary HIV infection (PHI) or chronic HIV …
antiretroviral therapy (cART) initiated during primary HIV infection (PHI) or chronic HIV …